trimethyltin has been researched along with Epilepsy, Temporal Lobe in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biamonte, F; Bonvissuto, D; Corvino, V; Geloso, MC; Giannetti, S; Lattanzi, W; Marchese, E; Michetti, F; Mongiovì, AM | 1 |
Imai, H; Kato, N; Minabe, Y; Nishimura, T; Sawa, A | 1 |
2 other study(ies) available for trimethyltin and Epilepsy, Temporal Lobe
Article | Year |
---|---|
The neuroprotective and neurogenic effects of neuropeptide Y administration in an animal model of hippocampal neurodegeneration and temporal lobe epilepsy induced by trimethyltin.
Topics: Animals; Antimetabolites; Apoptosis Regulatory Proteins; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Doublecortin Protein; Epilepsy, Temporal Lobe; Female; Gene Expression; Hippocampus; Immunohistochemistry; Injections, Intraventricular; Nerve Degeneration; Nerve Tissue Proteins; Neurogenesis; Neuropeptide Y; Neuroprotective Agents; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Neuropeptide Y; RNA; Trimethyltin Compounds | 2012 |
Beneficial effects of FK506 for experimental temporal lobe epilepsy.
Topics: Aggression; Animals; Anticonvulsants; Cell Survival; Dose-Response Relationship, Drug; Epilepsy, Temporal Lobe; Excitatory Amino Acid Agonists; Immunosuppressive Agents; In Situ Nick-End Labeling; Kainic Acid; Male; Rats; Rats, Sprague-Dawley; Seizures; Tacrolimus; Trimethyltin Compounds | 2006 |